Mobile Health Applications in the COVID-19 Pandemic: A Scoping Review of the Reviews

Background: Mobile health (m-Health) is a combination of electronic communications and medical information technology that has helped patients and health care workers during the COVID-19 outbreak. This study aimed to aggregate and highlight findings from existing review studies about applications of m-health to prevent COVID-19. Methods: This scoping review was conducted based on the Arksey and O'Malley framework after searching the PubMed, Web of Science, and Scopus databases from March 2020 to February 2022. Keywords for the search included the English words "Mobile health";" mobile apps";"corona disease";"COVID-19";and "review." Screening of articles was done in 4 stages. Results: Out of 37,569 papers found in the search, after the screening and review process, 22 articles were finally selected. From the analysis of the studies, 2 main categories emerged with the titles of "primary preventive applications" and "secondary preventive applications." Conclusion: M-health is used in both primary and secondary prevention. The m-health tools can be effective in controlling the spread of COVID-19 and improving the treatment process of this disease by providing various pieces of training related to COVID-19 as well as installing various programs to monitor the condition of patients. Also, m-Health can provide services through the exchange of treatment data between health care providers or between patients and health care providers, as well as provide appropriate training for the remote care needs of patients with COVID-19.

Mobile Health Applications in the COVID-19 Pandemic: A Scoping Review of the Reviews.

Background: Mobile health (m-Health) is a combination of electronic communications and medical information technology that has helped patients and health care workers during the COVID-19 outbreak. This study aimed to aggregate and highlight findings from existing review studies about applications of m-health to prevent COVID-19. Methods: This scoping review was conducted based on the Arksey and O'Malley framework after searching the PubMed, Web of Science, and Scopus databases from March 2020 to February 2022. Keywords for the search included the English words "Mobile health";" mobile apps"; "corona disease"; "COVID-19"; and "review." Screening of articles was done in 4 stages. Results: Out of 37,569 papers found in the search, after the screening and review process, 22 articles were finally selected. From the analysis of the studies, 2 main categories emerged with the titles of "primary preventive applications" and "secondary preventive applications." Conclusion: M-health is used in both primary and secondary prevention. The m-health tools can be effective in controlling the spread of COVID-19 and improving the treatment process of this disease by providing various pieces of training related to COVID-19 as well as installing various programs to monitor the condition of patients. Also, m-Health can provide services through the exchange of treatment data between health care providers or between patients and health care providers, as well as provide appropriate training for the remote care needs of patients with COVID-19.

Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment.

Currently, there are no specific and efficient vaccines or drugs for COVID-19, particularly in severe cases. A wide range of variations in the clinical symptoms of different patients attributed to genomic differences. Therefore, personalized treatments seem to play a critical role in improving these symptoms and even similar conditions. Prompted by the uncertainties in the area of COVID-19 therapies, we reviewed the published papers and concepts to gather and provide useful information to clinicians and researchers interested in personalized medicine and cell-based therapy. One novel aspect of this study focuses on the potential application of personalized medicine in treating severe cases of COVID-19. However, it is theoretical, as any real-world examples of the use of genuinely personalized medicine have not existed yet. Nevertheless, we know that stem cells, especially MSCs, have immune-modulatory effects and can be stored for future personalized medicine applications. This theory has been conjugated with some evidence that we review in the present study. Besides, we discuss the importance of personalized medicine and its possible aspects in COVID-19 treatment, then review the cell-based therapy studies for COVID-19 with a particular focus on stem cell-based therapies as a primary personalized tool medicine. However, the idea of cell-based therapy has not been accepted by several scientific communities due to some concerns of lack of satisfactory clinical studies; still, the MSCs and their clinical outcomes have been revealed the safety and potency of this therapeutic approach in several diseases, especially in the immune-mediated inflammatory diseases and some incurable diseases. Promising outcomes have resulted in that clinical studies are going to continue.

Role of Telemedicine and Telegenetics Framework for the Management of Cancer Patients During the COVID-19 Pandemic

After the outbreak of 2010 novel coronavirus infection (2010-nCoV) the disease has been regarded as an extremely fast -spreading respiratory tract infection causing mortality orldwide. It appears that patients with life -threatening tumors or immunosuppressed patients are at a greater risk of developing more severe symptoms induced by COVID-10. Thus, all patients should be provided with reliable consults and clinical treatment. The emergence of lockdown situations in more countries has moti ated all governments, healthcare services. and customers to further use on-line strategies in different areas with full access to healthcare. Telecommunications are beginning to be used in healthcare systems with the aim of providing a tailor specific approach to disease management. During the COVID-19 pandemic. antis iral drugs have failed to treat the disease. and no vaccine has been developed for the disease due to the pleiotropy and complexity of 2010-nCoV. Genome-base in estigations have brought new insights for the development of drugs to diagnose COVID-19 and predict its severity. In this re iew paper, we proposed a broad framework and interdisciplinary of telemedicine and genomic information for better management of patients and medical care professionals at different locations. By using a global telehealth network patients can be analyzed in a shorter time with lower costs. and better plans can be developed for the management of patients based on genetic profiles in different populations.